As of 2025-07-09, the Relative Valuation of Fulgent Genetics Inc (FLGT) is (32.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.52 USD, the upside of Fulgent Genetics Inc based on Relative Valuation is -265.6%.
The range of the Relative Valuation is (29.50) - (29.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 34.0x | 28.0x |
| Forward P/E multiples | 18.1x - 21.7x | 20.3x |
| Fair Price | (29.50) - (29.10) | (32.32) |
| Upside | -251.1% - -249.1% | -265.6% |
| Date | P/E |
| 2025-07-08 | -14.57 |
| 2025-07-07 | -14.40 |
| 2025-07-03 | -14.98 |
| 2025-07-02 | -15.01 |
| 2025-07-01 | -14.86 |
| 2025-06-30 | -14.84 |
| 2025-06-27 | -14.69 |
| 2025-06-26 | -14.63 |
| 2025-06-25 | -14.61 |
| 2025-06-24 | -14.57 |
| 2025-06-23 | -14.43 |
| 2025-06-20 | -14.58 |
| 2025-06-18 | -15.15 |
| 2025-06-17 | -15.12 |
| 2025-06-16 | -15.63 |
| 2025-06-13 | -15.45 |
| 2025-06-12 | -15.67 |
| 2025-06-11 | -16.21 |
| 2025-06-10 | -16.26 |
| 2025-06-09 | -16.28 |
| 2025-06-06 | -16.00 |
| 2025-06-05 | -15.54 |
| 2025-06-04 | -15.89 |
| 2025-06-03 | -15.80 |
| 2025-06-02 | -15.43 |
| 2025-05-30 | -15.47 |
| 2025-05-29 | -15.39 |
| 2025-05-28 | -15.34 |
| 2025-05-27 | -15.07 |
| 2025-05-23 | -15.16 |
| 2025-05-22 | -15.32 |
| 2025-05-21 | -15.14 |
| 2025-05-20 | -15.84 |
| 2025-05-19 | -15.84 |
| 2025-05-16 | -15.19 |
| 2025-05-15 | -14.96 |
| 2025-05-14 | -14.68 |
| 2025-05-13 | -15.15 |
| 2025-05-12 | -15.02 |
| 2025-05-09 | -14.71 |
| 2025-05-08 | -13.86 |
| 2025-05-07 | -13.92 |
| 2025-05-06 | -14.05 |
| 2025-05-05 | -14.60 |
| 2025-05-02 | -15.33 |
| 2025-05-01 | -12.88 |
| 2025-04-30 | -12.95 |
| 2025-04-29 | -13.53 |
| 2025-04-28 | -13.83 |
| 2025-04-25 | -14.09 |